rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Binxian Wei

Director

Company insider

Files Form 4 as: Director, Palisade Bio.

In numbers

Trades disclosed
19
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
3 Apr 2020
Last trade
10 Jun 2026
Last filed
12 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PALI Palisade BioDirector · Biotechnology · last 10 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 12 Jun 2026PALI Palisade BioBiotechnologySEC FORM 4 Code A—592,300filing
10 Jun 2026filed 12 Jun 2026PALI Palisade BioBiotechnologySEC FORM 4 Code M—20,200filing
10 Jun 2026filed 12 Jun 2026PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code M—20,200 at $0.00filing
10 Jun 2026filed 12 Jun 2026PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code M—20,200 at $0.00filing
10 Jun 2026filed 12 Jun 2026PALI Palisade BioBiotechnologySEC FORM 4 Code A—592,300filing
10 Jun 2026filed 12 Jun 2026PALI Palisade BioBiotechnologySEC FORM 4 Code M—20,200filing
6 Oct 2025filed 6 Nov 2025PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—60,600 at $0.00filing
6 Oct 2025filed 8 Oct 2025PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—510,700 at $0.00filing
4 Sep 2025filed 5 Sep 2025PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—18,800 at $0.00filing
21 Nov 2024filed 22 Nov 2024PALI Palisade BioBiotechnologySEC FORM 4 Code M—388 at $0.00filing
11 Jul 2024filed 15 Jul 2024PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—2,100 at $0.00filing
11 Jun 2024filed 12 Jun 2024PALI Palisade BioBiotechnologySEC FORM 4 Code M—465 at $0.00filing
21 Nov 2023filed 24 Nov 2023PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—5,820 at $0.00filing
21 Nov 2023filed 24 Nov 2023PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,880 at $0.00filing
11 Jun 2023filed 13 Jun 2023PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,980 at $0.00filing
11 Jun 2023filed 13 Jun 2023PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—9,580 at $0.00filing
18 Nov 2021filed 10 Feb 2022PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—48,340 at $0.00filing
1 Apr 2021filed 26 Apr 2021PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,000 at $0.00filing
3 Apr 2020filed 7 Apr 2020PALI Palisade Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John David FinleyCEO CFO · CEO CFO at Palisade Bio, filing Form 4 there in the last year
Mitchell Lawrence JonesOfficer · Officer at Palisade Bio, filing Form 4 there in the last year
Donald Allen WilliamsDirector · Director at Palisade Bio, filing Form 4 there in the last year
Robert Baltera Jr.Director · Director at Palisade Bio, filing Form 4 there in the last year
Emil ChuangDirector · Director at Palisade Bio, filing Form 4 there in the last year